-
Jimmy Carter Boosts Social Media Buzz For Merck's Blockbuster Drug
Tuesday, March 8, 2016 - 2:30pm | 355Read More...The latest data from TickerTags provides some surprising insight into the major impact former President Jimmy Carter’s melanoma diagnosis and treatment has had on the social media popularity of Merck & Co., Inc. (NYSE: MRK)’s Keytruda. TickerTags monitors social media sites to...
-
3 Mega Biotechs Leerink Loves
Monday, February 29, 2016 - 2:25pm | 357Read More...Leerink has released three new reports on some Outperform-rated big-name biotech stocks that the firm’s analysts like in coming months. Here’s a look at what the analysts had to say. Gilead Sciences, Inc. (NASDAQ: GILD) Analyst Geoffrey Porges has a positive view toward the stock,...
-
Bristol-Myers Looks To A Promising Future
Wednesday, February 17, 2016 - 9:17am | 358Read More...Pharmaceutical company Bristol-Myers Squibb Co (NYSE: BMY) has some big opportunities on the horizon, and analysts are taking notice. At a time when many pharma companies are beginning to worry about political battles over lowering drug prices, Bristol-Myers Squibb is hoping its bright future will...
-
Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds
Saturday, December 12, 2015 - 3:05pm | 705Read More...The global pharmaceutical industry has experienced a plethora of successful new products within the sector, more than offsetting global pricing pressures and supporting an outlook change to positive from stable for the entire industry. JPMorgan projects several important product launches and...
-
9 Healthcare Picks For 2016
Thursday, December 10, 2015 - 3:26pm | 1538Read More...The holiday season tends to make December feel like it's gone by in an instant, so many traders are already starting to gear up for the New Year. Since the Federal Reserve's upcoming policy meeting has the potential to upset markets in the coming week, many have already begun to craft their wish-...
-
Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders?
Tuesday, July 28, 2015 - 1:57pm | 429Read More...Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) were trading higher by more than 3 percent Tuesday after the company announced a new global collaboration with Sanofi (NYSE: SNY) to "discover, develop and commercialize new antibody cancer treatments in the emerging field of immune-...






